Eudald Casals1, Muling Zeng1, Marina Parra-Robert2, Guillermo Fernández-Varo2,3, Manuel Morales-Ruiz2,3,4, Wladimiro Jiménez2,3,*, Víctor Puntes5,6,7,* and Gregori Casals2,4*
1 School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, 529020 China
2 Service of Biochemistry and Molecular Genetics, Hospital Clinic Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036 Spain
3 Departament of Biomedicine, University of Barcelona, Barcelona, 08036 Spain
4 Working Group for the Biochemical Assessment of Hepatic Disease‐SEQC ML, Barcelona, 08036 Spain
5 Vall d'Hebron Research Institute (VHIR), Barcelona, 08035 Spain
6 Institut Català de Nanociència i Nanotecnologia (ICN2), CSIC, The Barcelona Institute of Science and Technology (BIST), Campus UAB, Bellaterra, Barcelona, 08193 Spain
7 Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, 08010 Spain